Skip to main content
. 2020 Feb 18;122(7):1109–1117. doi: 10.1038/s41416-020-0754-5

Table 1.

Indicators of test performance of gFOBT vs. FIT.

Type of stool test used for screening Differencea
gFOBT Total N = 94,290 FIT Total N = 28,217
n % (95% CI) n % (95% CI) % (95% CI)
Positive gFOBT/FIT results 5645 6.0 (5.8–6.1) 2185 7.7 (7.4–8.1) 1.7 (1.4–2.1)
Colonoscopy completion 4773 84.6 (83.6–85.5) 1716 78.5 (76.8–80.3) −6.1 (−8.0 to −4.1)
Detection rate
   Colorectal cancer 310 0.3 (0.3–0.4) 119 0.4 (0.3–0.5) 0.1 (0.0–0.2)
   Advanced adenoma 410 0.4 (0.4–0.5) 254 0.9 (0.8–1.0) 0.5 (0.3–0.6)
   Any advanced neoplasm 720 0.8 (0.7–0.8) 373 1.3 (1.2–1.5) 0.5 (0.4–0.7)
   Non-advanced adenoma 868 0.9 (0.9–1.0) 565 2.0 (1.8–2.2) 1.1 (0.9–1.3)
   Any adenoma 1278 1.4 (1.3–1.4) 819 2.9 (2.7–3.1) 1.5 (1.3–1.8)
Positive predictive valueb
   Colorectal cancer 310 6.5 (5.8–7.2) 119 6.9 (5.7–8.1) 0.4 (−1.0 to 1.8)
   Any advanced neoplasm 720 15.1 (14.1–16.1) 373 21.7 (19.8–23.7) 6.6 (4.5–8.9)

CI confidence interval, FIT faecal immunochemical test, gFOBT guaiac-based faecal occult blood test.

aDifferences with a 95% CI completely lower or higher than 0 are statistically significant, which means that the P value does not exceed 0.05.

bPositive predictive value is the percentage of participants with detected neoplasms relative to the number of participants with follow-up colonoscopy completed.